1. Home
  2. PRLB vs SION Comparison

PRLB vs SION Comparison

Compare PRLB & SION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRLB
  • SION
  • Stock Information
  • Founded
  • PRLB 1999
  • SION 2019
  • Country
  • PRLB United States
  • SION United States
  • Employees
  • PRLB N/A
  • SION N/A
  • Industry
  • PRLB Metal Fabrications
  • SION
  • Sector
  • PRLB Industrials
  • SION
  • Exchange
  • PRLB Nasdaq
  • SION NYSE
  • Market Cap
  • PRLB 928.0M
  • SION 871.7M
  • IPO Year
  • PRLB 2012
  • SION 2025
  • Fundamental
  • Price
  • PRLB $39.10
  • SION $19.10
  • Analyst Decision
  • PRLB Hold
  • SION Strong Buy
  • Analyst Count
  • PRLB 3
  • SION 1
  • Target Price
  • PRLB $43.00
  • SION $32.00
  • AVG Volume (30 Days)
  • PRLB 174.6K
  • SION 274.0K
  • Earning Date
  • PRLB 07-31-2025
  • SION 08-25-2025
  • Dividend Yield
  • PRLB N/A
  • SION N/A
  • EPS Growth
  • PRLB N/A
  • SION N/A
  • EPS
  • PRLB 0.60
  • SION N/A
  • Revenue
  • PRLB $499,205,000.00
  • SION N/A
  • Revenue This Year
  • PRLB $4.18
  • SION N/A
  • Revenue Next Year
  • PRLB $4.61
  • SION N/A
  • P/E Ratio
  • PRLB $64.79
  • SION N/A
  • Revenue Growth
  • PRLB N/A
  • SION N/A
  • 52 Week Low
  • PRLB $25.76
  • SION $7.26
  • 52 Week High
  • PRLB $46.73
  • SION $25.19
  • Technical
  • Relative Strength Index (RSI)
  • PRLB 47.06
  • SION N/A
  • Support Level
  • PRLB $38.88
  • SION N/A
  • Resistance Level
  • PRLB $39.86
  • SION N/A
  • Average True Range (ATR)
  • PRLB 0.84
  • SION 0.00
  • MACD
  • PRLB -0.21
  • SION 0.00
  • Stochastic Oscillator
  • PRLB 19.43
  • SION 0.00

About PRLB Proto Labs Inc. Common stock

Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. Proto Labs uses injection molding, computer numerical control machining, and 3-D printing to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

Share on Social Networks: